These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
376 related articles for article (PubMed ID: 27418267)
1. Phase IIa clinical study of [ Kondo A; Ishii H; Aoki S; Suzuki M; Nagasawa H; Kubota K; Minamimoto R; Arakawa A; Tominaga M; Arai H Ann Nucl Med; 2016 Nov; 30(9):608-618. PubMed ID: 27418267 [TBL] [Abstract][Full Text] [Related]
2. Albano D; Tomasini D; Bonù M; Giubbini R; Bertagna F Ann Nucl Med; 2020 Feb; 34(2):81-86. PubMed ID: 31773466 [No Abstract] [Full Text] [Related]
3. Determining the extent of tumor resection at surgical planning with Wakabayashi T; Hirose Y; Miyake K; Arakawa Y; Kagawa N; Nariai T; Narita Y; Nishikawa R; Tsuyuguchi N; Fukami T; Sasaki H; Sasayama T; Kondo A; Iuchi T; Matsuda H; Kubota K; Minamimoto R; Terauchi T; Nakazato Y; Kubomura K; Wada M Ann Nucl Med; 2021 Dec; 35(12):1279-1292. PubMed ID: 34406623 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of trans-1-amino-3-18F-fluorocyclobutanecarboxylic acid accumulation in low-grade glioma in chemically induced rat models: PET and autoradiography compared with morphological images and histopathological findings. Doi Y; Kanagawa M; Maya Y; Tanaka A; Oka S; Nakata N; Toyama M; Matsumoto H; Shirakami Y Nucl Med Biol; 2015 Aug; 42(8):664-72. PubMed ID: 26022202 [TBL] [Abstract][Full Text] [Related]
5. Multimodal Karlberg A; Berntsen EM; Johansen H; Myrthue M; Skjulsvik AJ; Reinertsen I; Esmaeili M; Dai HY; Xiao Y; Rivaz H; Borghammer P; Solheim O; Eikenes L World Neurosurg; 2017 Dec; 108():989.e1-989.e8. PubMed ID: 28844925 [TBL] [Abstract][Full Text] [Related]
6. 18F-FACBC PET/MRI in Diagnostic Assessment and Neurosurgery of Gliomas. Karlberg A; Berntsen EM; Johansen H; Skjulsvik AJ; Reinertsen I; Dai HY; Xiao Y; Rivaz H; Borghammer P; Solheim O; Eikenes L Clin Nucl Med; 2019 Jul; 44(7):550-559. PubMed ID: 31107743 [TBL] [Abstract][Full Text] [Related]
7. Regional distribution and kinetics of [18F]fluciclovine (anti-[18F]FACBC), a tracer of amino acid transport, in subjects with primary prostate cancer. Sörensen J; Owenius R; Lax M; Johansson S Eur J Nucl Med Mol Imaging; 2013 Feb; 40(3):394-402. PubMed ID: 23208700 [TBL] [Abstract][Full Text] [Related]
8. Diagnostic Performance and Safety of Positron Emission Tomography Using Wakabayashi T; Iuchi T; Tsuyuguchi N; Nishikawa R; Arakawa Y; Sasayama T; Miyake K; Nariai T; Narita Y; Hashimoto N; Okuda O; Matsuda H; Kubota K; Ito K; Nakazato Y; Kubomura K Asia Ocean J Nucl Med Biol; 2017; 5(1):10-21. PubMed ID: 28840134 [TBL] [Abstract][Full Text] [Related]
9. Michaud L; Beattie BJ; Akhurst T; Dunphy M; Zanzonico P; Finn R; Mauguen A; Schöder H; Weber WA; Lassman AB; Blasberg R Eur J Nucl Med Mol Imaging; 2020 Jun; 47(6):1353-1367. PubMed ID: 31418054 [TBL] [Abstract][Full Text] [Related]
10. Trans-1-amino-3-18F-fluorocyclobutanecarboxylic acid (anti-18F-FACBC) is a feasible alternative to 11C-methyl-L-methionine and magnetic resonance imaging for monitoring treatment response in gliomas. Sasajima T; Ono T; Shimada N; Doi Y; Oka S; Kanagawa M; Baden A; Mizoi K Nucl Med Biol; 2013 Aug; 40(6):808-15. PubMed ID: 23701701 [TBL] [Abstract][Full Text] [Related]
12. Prospective evaluation of Jambor I; Kuisma A; Kähkönen E; Kemppainen J; Merisaari H; Eskola O; Teuho J; Perez IM; Pesola M; Aronen HJ; Boström PJ; Taimen P; Minn H Eur J Nucl Med Mol Imaging; 2018 Mar; 45(3):355-364. PubMed ID: 29147764 [TBL] [Abstract][Full Text] [Related]
13. A PET/MRI study towards finding the optimal [ Elschot M; Selnæs KM; Sandsmark E; Krüger-Stokke B; Størkersen Ø; Tessem MB; Moestue SA; Bertilsson H; Bathen TF Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):695-703. PubMed ID: 27817158 [TBL] [Abstract][Full Text] [Related]
14. Diagnosis of Brain Tumors Using Amino Acid Transport PET Imaging with Tsuyuguchi N; Terakawa Y; Uda T; Nakajo K; Kanemura Y Asia Ocean J Nucl Med Biol; 2017; 5(2):85-94. PubMed ID: 28660218 [TBL] [Abstract][Full Text] [Related]
15. 18F-fluoro-L-thymidine and 11C-methylmethionine as markers of increased transport and proliferation in brain tumors. Jacobs AH; Thomas A; Kracht LW; Li H; Dittmar C; Garlip G; Galldiks N; Klein JC; Sobesky J; Hilker R; Vollmar S; Herholz K; Wienhard K; Heiss WD J Nucl Med; 2005 Dec; 46(12):1948-58. PubMed ID: 16330557 [TBL] [Abstract][Full Text] [Related]
16. Phase I clinical study of NMK36: a new PET tracer with the synthetic amino acid analogue anti-[18F]FACBC. Asano Y; Inoue Y; Ikeda Y; Kikuchi K; Hara T; Taguchi C; Tokushige T; Maruo H; Takeda T; Nakamura T; Fujita T; Kumagai Y; Hayakawa K Ann Nucl Med; 2011 Jul; 25(6):414-8. PubMed ID: 21409348 [TBL] [Abstract][Full Text] [Related]
17. Anti-3-18F-FACBC (18F-Fluciclovine) PET/CT of Breast Cancer: An Exploratory Study. Tade FI; Cohen MA; Styblo TM; Odewole OA; Holbrook AI; Newell MS; Savir-Baruch B; Li X; Goodman MM; Nye JA; Schuster DM J Nucl Med; 2016 Sep; 57(9):1357-63. PubMed ID: 27056619 [TBL] [Abstract][Full Text] [Related]
18. Image Guided Planning for Prostate Carcinomas With Incorporation of Anti-3-[18F]FACBC (Fluciclovine) Positron Emission Tomography: Workflow and Initial Findings From a Randomized Trial. Schreibmann E; Schuster DM; Rossi PJ; Shelton J; Cooper S; Jani AB Int J Radiat Oncol Biol Phys; 2016 Sep; 96(1):206-13. PubMed ID: 27511856 [TBL] [Abstract][Full Text] [Related]
19. Localized prostate cancer detection with 18F FACBC PET/CT: comparison with MR imaging and histopathologic analysis. Turkbey B; Mena E; Shih J; Pinto PA; Merino MJ; Lindenberg ML; Bernardo M; McKinney YL; Adler S; Owenius R; Choyke PL; Kurdziel KA Radiology; 2014 Mar; 270(3):849-56. PubMed ID: 24475804 [TBL] [Abstract][Full Text] [Related]
20. 11C-CHO PET in optimization of target volume delineation and treatment regimens in postoperative radiotherapy for brain gliomas. Li FM; Nie Q; Wang RM; Chang SM; Zhao WR; Zhu Q; Liang YK; Yang P; Zhang J; Jia HW; Fang HH Nucl Med Biol; 2012 Apr; 39(3):437-42. PubMed ID: 22172386 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]